Current treatment options for local residual nasopharyngeal carcinoma (Q26852207)

main subject

nasopharynx carcinoma

1 reference

local neoplasm recurrence

3 April 2019

3 references

3 April 2019

24 June 2019

3 October 2019

3 references

3 April 2019

24 June 2019

3 October 2019

nasopharyngeal neoplasm

2 references

24 June 2019

3 October 2019

S. D. Stoker

1

1 reference

J. N. A. van Diessen

2

1 reference

J. P. de Boer

3

1 reference

B. Karakullukcu

4

1 reference

C. R. Leemans

5

1 reference

I. B. Tan

6

1 reference

language of work or name

1 reference

December 2013

1 reference

Current Treatment Options in Oncology

1 December 2013

3 references

3 April 2019

24 June 2019

3 October 2019

3 references

24 June 2019

3 October 2019

14

1 reference

issue

4

1 reference

page(s)

475-91

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

copyright license

start time

16 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

A prospective study: current problems in radiotherapy for nasopharyngeal carcinoma in yogyakarta, indonesia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Remarkable response to photodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma: a case report

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Temoporfin mediated photodynamic therapy in patients with local persistent and recurrent nasopharyngeal carcinoma after curative radiotherapy: a feasibility study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

History and growth of radiation oncology in Indonesia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Recurrent nasopharyngeal carcinoma: surgical salvage vs. additional chemoradiation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Treatment for metastatic nasopharyngeal carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: work package 1.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Photodynamic therapy for residual or recurrent cancer of the nasopharynx

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Nasopharyngeal carcinoma: local control by megavoltage irradiation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Photodynamic therapy for recurrent nasopharyngeal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Endoscopic nasopharyngectomy for locally recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-013-0261-5

Fractionated stereotactic radiotherapy with vagina carotica protection technique for local residual nasopharyngeal carcinoma after primary radiotherapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3841576

Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma

28 November 2018

1 reference

12 December 2020

Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy

1 reference

12 December 2020

Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma

1 reference

12 December 2020

Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma

1 reference

12 December 2020

Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma

1 reference

12 December 2020

Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose

1 reference

12 December 2020

Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy

1 reference

12 December 2020

Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma

1 reference

12 December 2020

Nasopharyngeal carcinoma

1 reference

12 December 2020

Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses beneficial?

1 reference

12 December 2020

Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma

1 reference

12 December 2020

Nasopharyngectomy: does the approach to the nasopharynx influence survival?

1 reference

12 December 2020

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group

1 reference

12 December 2020

Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma

1 reference

12 December 2020

Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma

1 reference

12 December 2020

Surgical salvage of persistent or recurrent nasopharyngeal carcinoma with maxillary swing approach - Critical appraisal after 2 decades

1 reference

12 December 2020

Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma

1 reference

12 December 2020

The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma

1 reference

12 December 2020

A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients

1 reference

12 December 2020

Prognostic factors for survival after salvage reirradiation of head and neck cancer

1 reference

12 December 2020

10.1007/S11864-013-0261-5

Identifiers

DOI

1 reference

Dimensions Publication ID

4700293

1033048096

0 references

4700293

1 reference

1 reference

1 reference